SCHEDULE 13G/A

Stoke Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 86150R107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Redmile Group, LLC

  Shares: 4,375,931.00 · Class: 8.0%

• Jeremy C. Green

  Shares: 4,375,931.00 · Class: 8.0%

• Redmile Biopharma Investments III, L.P.

  Shares: 3,505,612.00 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.